In a first for biopharma, a quantum computer has bested classical hardware in generating new and viable drug molecules.
An international team led by Insilico Medicine, a Hong Kong-based generative AI-driven drug discovery company, simultaneously ran generative artificial...
Welcome to In Vivo
Create an account to read this article
Already a subscriber?